Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of developing flu-related complications.
Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of developing flu-related complications.
For some people, getting the flu can lead to more serious health complications. This may include older adults, people living with certain chronic health conditions, and people whose immune systems are weakened by a medical condition or treatment.
If you qualify and choose to participate, you will receive one injection of either the investigational medication or a placebo. The study is double-blind, meaning neither you nor the study team will know which one you receive during the study.
Participation lasts approximately 29 weeks, not including the screening period. During the study, participants will be asked to complete regular check-ins about possible flu-like symptoms and attend study visits as required.
You may qualify if you:
Adults with overweight or obesity who do not have type 2 diabetes may qualify for a clinical research study evaluating
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase
Researchers are evaluating an investigational treatment for adults who have type 2 diabetes and cardiovascular disease and may be at
Researchers are evaluating an investigational oral treatment for adults who are overweight and may be at risk of developing certain
Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of
Individuals with chronic obstructive pulmonary disease (COPD) who continue to experience symptoms or flare-ups despite treatment may qualify for a